USSTOCK.TODAY
Regular Market
Log in Sign up

United Therapeutics Q3 Earnings Miss Estimates, Revenue Beats

Associated Press +2 · ·by G4L

UTHR
UTHR United Therapeutics Corp
$582.46 +3.64%
View chart & analysis →
  1. 1United Therapeutics reported Q3 earnings of $258.6 million.
  2. 2United Therapeutics' Q3 earnings per share of $5.71 fell below the average estimate of $5.85 from 6 analysts surveyed by Zacks Investment Research.
  3. 3United Therapeutics' revenue of $832.5 million for the period exceeded market expectations.

So what's the key point?

United Therapeutics' third-quarter earnings were lower than what experts expected. However, revenue was higher than expected.

Source Associated Press +2 · View original ↗

Related 3-line summaries

United Therapeutics stock price and earnings outlook diverge ahead of Q3 results Earnings Whispers +1 · Oct 28Liquidia Corporation reaches $380.7 million settlement with United Therapeutics Corporation Investing.com · Oct 14Liquidia Corp shares surge 44.3% in premarket trading on settlement with United Therapeutics Investing.com +2 · Oct 14
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news